Omada Health, Inc.
For the period ended Mar 31, 2026. Filed May 8, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 8, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations and Comprehensive Loss
(in thousands, except per-share data, unaudited)
| Three Months Ended March 31, | |||
|---|---|---|---|
| 2026 | 2025 | ||
| Revenue | |||
| Services (1) | $69,594 | $49,496 | |
| Hardware (2) | 8,454 | 5,467 | |
| Total revenue | 78,048 | 54,963 | |
| Cost of revenue | |||
| Services (3) | 14,449 | 12,744 | |
| Hardware | 14,906 | 10,319 | |
| Total cost of revenue | 29,355 | 23,063 | |
| Gross profit | 48,693 | 31,900 | |
| Operating expenses | |||
| Research and development (4) | 12,697 | 8,806 | |
| Sales and marketing (5) | 26,787 | 20,170 | |
| General and administrative (6) | 13,990 | 11,320 | |
| Total operating expenses | 53,474 | 40,296 | |
| Operating loss | (4,781) | (8,396) | |
| Other income (expense), net | |||
| Interest expense | (18) | (1,074) | |
| Interest income | 1,829 | 542 | |
| Change in fair value of warrant liabilities | - | (520) | |
| Total other income (expense), net | 1,811 | (1,052) | |
| Loss before provision for income taxes | (2,970) | (9,448) | |
| Provision for income taxes | - | - | |
| Net loss and comprehensive loss | $(2,970) | $(9,448) | |
| Net loss per share - basic and diluted | $(0.05) | $(1.15) | |
| Weighted-average shares outstanding - basic and diluted | 58,923 | 8,241 | |
(1)Includes amounts from a related party of $46.0 million and $29.9 million for the three months ended March 31, 2026 and 2025, respectively.
(2)Includes amounts from a related party of $5.1 million and $3.4 million for the three months ended March 31, 2026 and 2025, respectively.
(3)Includes amounts from a related party of $1.3 million and $1.2 million for the three months ended March 31, 2026 and 2025, respectively.
(4)Includes amounts from a related party of $0.7 million and $0.5 million for the three months ended March 31, 2026 and 2025, respectively.
(5)Includes amounts from a related party of $8.4 million and $5.6 million for the three months ended March 31, 2026 and 2025, respectively.
(6)Includes amounts from a related party of $0.5 million and $0.3 million for the three months ended March 31, 2026 and 2025, respectively.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.